Abstract
Purpose Uveal melanoma continues to present problems when attempting to predict disease progression. This study attempts to identify markers indicative of the biological characteristics of cells isolated from samples of uveal melanoma, including adhesion (ICAM-1), immune reactivity (MHC Class I and II), cell cycle control (c-erbB-2, c-myc) and apoptosis control (bcl-2, p53) using dual parameter (DNA/MoAb) flow cytometry.
Methods Sixty-three fresh tissue samples from choroidal melanomas were taken at enucleation. Samples were assayed for DNA content and cell cycle, the above antibodies together with positive (PHM-5) and negative (2° FITC Ab) controls. The clinical parameters sex, age, tumour location, cell type, tumour volume and presence of metastases were compared with the results and analysed with the non-parametric Mann-Whitney u-t-test.
Results ICAM-1 expression proved to be the most clinically relevant, being present on a higher proportion of cells in tumours > 2000 mm3 (median 38, n = 19) compared with the smaller tumours < 2000 mm3 (median 17, n = 26) (p = 0.0015). Metastatic disease was present in 11 patients and did not correlate with any of the surface markers. C-myc, c-erbB-2 and MHC Class II expression were associated with cell type, all showing greater expression in spindle cell tumours than mixed/ epithelial types.
Conclusion These results show flow cytometry as a quick, easy method to provide a ‘phenotypic profile’ for these tumours, and identifies cell cycle control and adhesion molecule expression as important areas for further investigation. c-erbB-2 and bcl-2 positivity was typically seen on over 60% cells in each sample, indicating two potential targets for therapeutic intervention.
Similar content being viewed by others
Article PDF
References
Lawry J, Smith MO, Parsons MA, Rennie IG . Simultaneous cell cycle and phenotypic analysis of primary uveal melanoma by flow cytometry. Eye 1998;12:431–9.
Mooy C, Vissers K, Luyten G, Mulder A, Stijnen T, de Jong P, et al. DNA flow cytometry in uveal melanomas: the effect of pre-enucleation irradiation. Br J Ophthalmol 1995;79:174–7.
Fuchs M, Wohlrab W, Klapperstuck T, Fuchs U . DNA flow cytometry of malignant melanoma of the choroid. Ophthalmologe 1993;90:496–500.
Royds JA, Sharrard RM, Parsons MA, Lawry J, Rees RC, Cottam D, et al. c-myc oncogene expression in ocular melanomas. Graefes Arch Clin Exp Ophthalmol 1992;230:366–71.
Binder C, Marx D, Overhoff R, Binder L, Schauer A, Hiddermann W . Bcl-2 protein expression in breast cancer in relation to established prognostic factors and other clinicopathological variables. Ann Oncol 1995;6:1005–10.
Grover R, Ross DA, Richman PI, Robinson B, Wilson GD . c-myc oncogene expression in human melanoma and its relationship with tumour antigenicity. Eur J Surg Oncol 1996;22:342–6.
Ma D, Luyten GF, Luider TM, Niederkorn JY . Relationship between natural killer cell susceptibility and metastases of human uveal melanoma cells in a murine model. Invest Ophthalmol Vis Sci 1995;36:435–41.
Heymann D, Godard A, Raher S, Ringeard S, Lassort D, Blanchard F, et al. Human interleukin for DA cells/ leukaemia inhibitory factor and oncostatin M enhances membrane expression of intercellular adhesion molecule-1 on melanoma cells but not the shedding of its soluble form. Cytokine 1995;7:lll–7.
Richardson RP, Lawry J, Rees RC, Rennie IG . DNA index and % S-phase fraction in posterior uveal melanoma: a 5 year prospective study of fresh tissue using flow cytometry. Eye 1997;ll:629–34.
Elavathil LJ, LeRiche J, Rootman J, Gallagher RP, Phillips D . Prognostic value of DNA ploidy as assessed with flow cytometry in uveal melanoma. Can J Ophthalmol 1995;30:360–5.
Coleman K, Baak JP, Dorman A, Mullaney J, Curran B, Tiernan D, et al. DNA ploidy studies in choroidal melanoma. Am J Ophthalmol 1993;115:376–83.
Karlsson M, Boeryd B, Carstensen J, Franlund B, Gustafsson B, Kagedal B, et al. Correlation of Ki67 and PCNA to DNA ploidy, S-phase fraction and survival in uveal melanoma. Eur J Cancer 1996;32:357–62.
van Dam PA, Vergote IB, Lowe DG, Watson JV, van Damme P, van der Auwere JC, et al. Expression of c-erbB-2, c-myc, c-ras oncoproteins, IGFr-1 and EGFr in ovarian carcinoma. J Clin Pathol 1994;47:914–20.
Wagner U, Sauter G, Moch H, NovotnaH, Epper R, Mihatsch MJ, et al. Patterns of p53, erbB-2, EGFr expression in premalignant lesions of the urinary bladder. Hum Pathol 1995;26:970–8.
Eccles SA, Modjtdhedi H, Box G, Court W, Sandle J, Dean CJ . Significance of the c-erbB family of receptor tyrosine kinases in metastatic cancer and their potential as targets for immunotherapy. Invasion Metastases 1994;14:337–47.
Stal O, Sullivan S, Sun XF, Wingren S, Nordenskjold B . Simultaneous analysis of C-erbB2 expression and DNA staining in breast cancer using flow cytometry. Cytometry 1994;16:160–8.
Ryan JJ, Prochownik E, Gottlieb CA, Apel IJ, Merino R, Nunez G, et al. c-myc, and bcl-2 modulate p53 function by altering p53 subcellular trafficking during the cell cycle. Proc Natl Acad Sci USA 1994;91:5878–82.
Meecham WJ, Char DH, Kaleta Michaels S . Infiltrating lymphocytes and antigen expression in uveal melanoma. Ophthalmic Res 1992;24:20–6.
Author information
Authors and Affiliations
Corresponding author
Additional information
The flow cytometry facility is supported by the Yorkshire Cancer Research
Rights and permissions
About this article
Cite this article
Lawry, J., Currie, Z., Smith, M. et al. The correlation between cell surface markers and clinical features in choroidal malignant melanomas. Eye 13, 301–308 (1999). https://doi.org/10.1038/eye.1999.79
Received:
Accepted:
Issue Date:
DOI: https://doi.org/10.1038/eye.1999.79